EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quinazoline-2,4(1H,3H)-dione derivatives as new class of CB1 Agonists: A pharmacophore-based virtual screening workflow and drug discovery

Abdellah El Aissouq iD, Mourad Stitou, Mohamed Enneiymy, Said El Rhabori, Hicham Zaitan, Abdelkrim Ouammou, Fouad Khalil

F1000Research · 11.03.2026 · 14 · 1322

DOI: 10.12688/f1000research.171433.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, online erschienen am 11.03.2026. Verfasst von Abdellah El Aissouq und 6 weiteren Autor:innen. Beteiligte Einrichtung: Universite Sidi Mohamed Ben Abdellah Faculte des Sciences et Techniques de Fes, Fes, Fes-Boulemane, Morocco. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB1, Drug Discovery, Quinazolines. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: not applicable.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The cannabinoid 1 (CB1) receptor is the primary target of Δ 9 -tetrahydrocannabinol (Δ 9 -THC), the psychoactive component of cannabis sativa (commonly known as “kif” in Morocco).

Methods

Here, we identified novel CB1 agonists using virtual screening approaches. First, we developed a pharmacophore model based on the known CB1 agonist AM11542 and screened a database of over three million compounds. Molecular docking using AutoDock Vina identified 61 hits with binding affinities of less than -9.00 Kcal/mol. Subsequent ADME-Tox (absorption, distribution, metabolism, excretion, and toxicity) analysis narrowed the selection to 18 promising candidates.

Results

Among these, three agonists exhibited strong characteristics, including a favorable inhibition constant (Ki) and key hydrogen-bond interactions with critical residues in the CB1 binding pocket: PUBChem157251136 (Ki=2.09 nM), ZINC64438485 (Ki= 0.262 nM) and ZINC64438506 (Ki =0.244 nM). These agonists formed stable hydrogen bonds with CB1 binding pocket residues (Ser383, Ser173, His178 and Thr197). Molecular dynamics simulations (100 ns, GROMACS) demonstrated structural stability (RMSD < 1 nm) and low conformational flexibility (RMSF < 1 nm) for all complexes. MM-GBSA binding free energy calculations further confirmed the thermodynamic stability of all complexes, with interaction energies ranging from -30.59 to -49.98 kcal/mol. These comprehensive simulations confirm that all identified agonist complexes maintain stable binding conformations with optimal interaction profiles characteristic of CB1 receptor activation.

Conclusion

These results could pave the way for researching and developing new quinazolinz-2, 4(1H, 3H)-Dione derivatives as a new class of CB1 receptor agonists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Cannabinoid, CB1Drug DiscoveryQuinazolinesMolecular Docking SimulationHumansWorkflowDrug Evaluation, PreclinicalPharmacophore

Stichwörter der Autor:innen

3H)-dione derivatives4(1HCB1 agonistslead discoverypharmacophore based virtual screeningquinazoline-2

Substanzen

Receptor, Cannabinoid, CB1Quinazolines

Autor:innen und Institutionen

  • Universite Sidi Mohamed Ben Abdellah Faculte des Sciences et Techniques de Fes, Fes, Fes-Boulemane, Morocco.
  • Universite Ibn Zohr Faculte des Sciences Agadir, Agadir, Souss-Massa-Draa, Morocco.
  • Universite Sidi Mohamed Ben Abdellah Faculte des Sciences Dhar El Mahraz-Fes, Fes, Fes-Boulemane, Morocco.

ORCID-Profile: Abdellah El Aissouq

Förderung

  • not applicable

Zitieren

APA

El Aissouq, A., Stitou, M., Enneiymy, M., El Rhabori, S., Zaitan, H., Ouammou, A., & Khalil, F. (2026). Quinazoline-2,4(1H,3H)-dione derivatives as new class of CB1 Agonists: A pharmacophore-based virtual screening workflow and drug discovery. F1000Research, 14, 1322. https://doi.org/10.12688/f1000research.171433.3

Vancouver

El Aissouq A, Stitou M, Enneiymy M, El Rhabori S, Zaitan H, Ouammou A, et al. Quinazoline-2,4(1H,3H)-dione derivatives as new class of CB1 Agonists: A pharmacophore-based virtual screening workflow and drug discovery. F1000Research. 2026;14:1322. doi:10.12688/f1000research.171433.3

BibTeX
@article{ElAissouq2026,
  author = {El Aissouq, Abdellah and Stitou, Mourad and Enneiymy, Mohamed and El Rhabori, Said and Zaitan, Hicham and Ouammou, Abdelkrim and Khalil, Fouad},
  title = {Quinazoline-2,4(1H,3H)-dione derivatives as new class of CB1 Agonists: A pharmacophore-based virtual screening workflow and drug discovery},
  journal = {F1000Research},
  year = {2026},
  volume = {14},
  pages = {1322},
  doi = {10.12688/f1000research.171433.3}
}
Kostenlos starten →